Table 2 Cox regression analysis of significant predictors for long-term urinary continence.
Variable | Univariate cox regression | Multivariate cox regression | ||
|---|---|---|---|---|
OR (95%CI) | P | OR (95%CI) | P | |
BMI | 1.002 (0.956–1.050) | 0.940 | ||
Age | 0.963 (0.945–0.981) | <0.001 | 0.978 (0.958–0.998) | 0.005 |
PSA | 0.998 (0.985–1.011) | 0.729 | ||
PV | 0.998 (0.989–1.007) | 0.613 | ||
PW | 1.050 (0.814–1.354) | 0.710 | ||
PH | 0.975 (0.797–1.192) | 0.803 | ||
ITD | 1.098 (0.993–1.215) | 0.068 | ||
BFW | 1.086 (0.879–1.342) | 0.444 | ||
SW | 0.800 (0.652–0.983) | 0.034 | ||
AD | 0.660 (0.520–0.837) | <0.001 | ||
API | 1.087 (0.943–1.254) | 0.250 | ||
APM | 0.980 (0.830–1.155) | 0.806 | ||
APO | 0.934 (0.811–1.077) | 0.349 | ||
PD | 1.046 (0.918–1.191) | 0.499 | ||
PDI | 1.467 (1.172–1.836) | <0.001 | ||
BWI | 1.548 (1.223–1.960) | <0.001 | ||
SWI | 1.504 (0.965–2.346) | 0.072 | ||
TWI | 1.696 (1.329–2.164) | <0.001 | 1.627 (1.268–2.088) | <0.001 |
BFW/PW | 1.073 (0.584–1.969) | 0.821 | ||
SW/PW | 0.267 (0.089-0.800) | 0.018 | ||
PD/PH | 1.121 (0.811–1.549) | 0.490 | ||
ASP | 1.005 (0.989–1.021) | 0.550 | ||
Presence of median lobe | 0.989 (0.681–1.436) | 0.954 | ||
Biopsy ISUP grade group | ||||
2 vs. 1 | 0.977 (0.697–1.371) | 0.894 | ||
3 vs. 1 | 0.828 (0.587–1.169) | 0.283 | ||
4 or 5 vs. 1 | 0.848 (0.585–1.230) | 0.385 | ||
Clinical Tstage | ||||
T2a vs. T1 | 0.957 (0.647–1.415) | 0.824 | 0.915 (0.617–1.355) | 0.657 |
T2b、T2c vs. T1 | 0.754 (0.483–1.178) | 0.215 | 0.781 (0.499–1.222) | 0.279 |
T3 vs. T1 | 0.472 (0.295–0.756) | 0.002 | 0.473 (0.294–0.761) | 0.002 |
Risk group | ||||
Intermediate risk vs. low risk | 0.921 (0.640–1.325) | 0.657 | ||
High risk vs. low risk | 0.855 (0.581–1.259) | 0.428 | ||
Locally advanced vs. low risk | 0.482 (0.308–0.754) | 0.001 | ||
Nerve-sparing | 1.579 (1.219–2.047) | <0.001 | ||